The Farm Energy Company have been working closely with GlaxoSmithKline to assist them in achieving their target of sourcing 100% of their global electricity from renewable sources by 2025.

About The Project

The Irvine project is a key contributor to this target particularly given the high energy requirements generated at this GSK facility.

Technologies Used

Wind Turbine Illustration

8MW of Wind

(2 Enercon E126 EP3 turbines, with a tip height of 150m)

Solar Panel Illustration

20MW of Field Scale Solar

(Installation of approximately 45,000 modules)


Consent was granted by North Ayrshire Council in 2019. This was achieved through unanimous approval at Planning Committee following ongoing and detailed discussions with the Local Planning Authority during the determination period.

This ensured concerns regarding Glasgow Prestwick Airport's radar, landscape and visual impact and ecology were dealt with collaboratively and efficiently.

My Contribution Professional Senior Engineer Holding Blueprint While Being Involved Wind Turbines Project
Foreman Businessman Solar Energy Station

Key Benefits

The project represents significant investment in the local area, injecting investment into the local economy and creating temporary construction jobs and operational jobs.

Furthermore, the provision of renewable energy solutions to the GSK plant will secure future investment into this substantial local employer to secure long term job security for staff.


Construction is due to commence in Summer 2021 with connection in early 2022.

Once constructed, all of the power will be sold to GSK under a long term PPA agreement providing a long term, low cost renewable energy solution.

GSK Aerial